Adnkronos "The digitalization of specimens is the first important step toward the application of artificial intelligence algorithms. Today, molecular biology, digital pathology, and artificial intelligence truly offer unprecedented opportunities." This was stated by Daniela Massi, President of IMI, at the opening of the 32nd National Congress of the Italian Melanoma Intergroup in Bologna. She also emphasized the importance of making NGS tests for the diagnosis and prognosis of atypical melanocytic tumors eligible for reimbursement.
https://www.youtube.com/watch?v=iVi9-mS8J64
Continue on the app
The news of your city, in real time.
Open in app